These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The treated natural history of high risk superficial bladder cancer: 15-year outcome. Cookson MS; Herr HW; Zhang ZF; Soloway S; Sogani PC; Fair WR J Urol; 1997 Jul; 158(1):62-7. PubMed ID: 9186324 [TBL] [Abstract][Full Text] [Related]
8. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. Herr HW J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association. Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T; Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609 [TBL] [Abstract][Full Text] [Related]
10. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations. Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315 [TBL] [Abstract][Full Text] [Related]
11. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy. Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686 [TBL] [Abstract][Full Text] [Related]
12. [Results of BCG in the treatment of pTa and pT1 bladder tumors. Evaluation of a long protocol using 75 mg of Pasteur strain BCG]. Ayed M; Ben Hassine L; Ben Slama R; Chelbi N; Ghozzi S; Drissi H; Jemni M; Chebil M Prog Urol; 1998 Apr; 8(2):206-10. PubMed ID: 9615929 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer. Jancke G; Damm O; Rosell J; Jahnson S Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266 [TBL] [Abstract][Full Text] [Related]
14. [Modern follow-up strategies for the treatment of patients with superficial bladder carcinoma]. Werner W; Smesny S; Schubert J Z Arztl Fortbild Qualitatssich; 2000 Aug; 94(6):519-27. PubMed ID: 10996943 [TBL] [Abstract][Full Text] [Related]
15. [Superficial grade G2 tumors of the bladder: recurrence, progression, prognosis]. Sebe P; Lebret T; Molinie V; Herve JM; Yonneau L; Lugagne PM; Saporta F; Orsoni JL; Butreau M; Botto H Prog Urol; 2003 Sep; 13(4):608-12. PubMed ID: 14650291 [TBL] [Abstract][Full Text] [Related]
16. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors. Palou J; Rodríguez-Rubio F; Millán F; Algaba F; Rodríguez-Faba O; Huguet J; Villavicencio H Urology; 2009 Jun; 73(6):1313-7. PubMed ID: 19362341 [TBL] [Abstract][Full Text] [Related]
17. [Analysis of prognostic factors in superficial bladder tumors]. Páez Borda A; Martín Osés E; de la Cal López M; Llorente Abarca C; Berenguer Sánchez A Arch Esp Urol; 1997 Mar; 50(2):121-6. PubMed ID: 9206936 [TBL] [Abstract][Full Text] [Related]
18. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? Brauers A; Buettner R; Jakse G J Urol; 2001 Mar; 165(3):808-10. PubMed ID: 11176474 [TBL] [Abstract][Full Text] [Related]
19. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ. Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389 [TBL] [Abstract][Full Text] [Related]
20. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis. Uchida A; Yonou H; Hayashi E; Iha K; Oda M; Miyazato M; Oshiro Y; Hokama S; Sugaya K; Ogawa Y Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]